Abera Bioscience
Phase 1Abera Bioscience is a biotechnology company developing next-generation mucosal vaccines based on its novel vaccine platforms.
Founded
2015
Focus
Vaccines
About
Abera Bioscience is a biotechnology company developing next-generation mucosal vaccines based on its novel vaccine platforms.
Funding History
2Total raised: $3.7M
Seed$3.2MIndustrifondenApr 15, 2021
Grant$500KSwedish Innovation Agency (Vinnova)Oct 15, 2020
Company Info
TypePrivate
Founded2015
LocationStockholm, Sweden
StagePhase 1
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile